Healthcare & Life Sciences
Black Diamond Therapeutics
United Stateswww.blackdiamondtherapeutics.com
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Black Diamond Therapeutics develops precision oncology therapies by targeting oncogenic mutations across genetically defined patient populations, with a focus on non-small cell lung cancer and glioblastoma.
Explore Black Diamond Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.